Your browser doesn't support javascript.
loading
Elucidating the molecular mechanisms associated with TARS2-related mitochondrial disease.
Zheng, Wen-Qiang; Pedersen, Signe Vandal; Thompson, Kyle; Bellacchio, Emanuele; French, Courtney E; Munro, Benjamin; Pearson, Toni S; Vogt, Julie; Diodato, Daria; Diemer, Tue; Ernst, Anja; Horvath, Rita; Chitre, Manali; Ek, Jakob; Wibrand, Flemming; Grange, Dorothy K; Raymond, Lucy; Zhou, Xiao-Long; Taylor, Robert W; Ostergaard, Elsebet.
Afiliação
  • Zheng WQ; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
  • Pedersen SV; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Thompson K; Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen 2100, Denmark.
  • Bellacchio E; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • French CE; Area di Ricerca Genetica e Malattie Rare, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy.
  • Munro B; Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Pearson TS; Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Vogt J; Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Diodato D; West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham Women's Hospital, Birmingham B15 2TG, UK.
  • Diemer T; Neuromuscular and Neurodegenerative Disease Unit, Children Hospital Bambino Gesù, Rome 00165, Italy.
  • Ernst A; Department of Clinical Genetics, Aalborg University Hospital, Aalborg 9000, Denmark.
  • Horvath R; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg 9000, Denmark.
  • Chitre M; Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Ek J; Department of Paediatric Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Wibrand F; Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen 2100, Denmark.
  • Grange DK; Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen 2100, Denmark.
  • Raymond L; Department of Pediatrics, Division Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Zhou XL; Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Taylor RW; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
  • Ostergaard E; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Hum Mol Genet ; 31(4): 523-534, 2022 02 21.
Article em En | MEDLINE | ID: mdl-34508595
ABSTRACT
TARS2 encodes human mitochondrial threonyl tRNA-synthetase that is responsible for generating mitochondrial Thr-tRNAThr and clearing mischarged Ser-tRNAThr during mitochondrial translation. Pathogenic variants in TARS2 have hitherto been reported in a pair of siblings and an unrelated patient with an early onset mitochondrial encephalomyopathy and a combined respiratory chain enzyme deficiency in muscle. We here report five additional unrelated patients with TARS2-related mitochondrial diseases, expanding the clinical phenotype to also include epilepsy, dystonia, hyperhidrosis and severe hearing impairment. In addition, we document seven novel TARS2 variants-one nonsense variant and six missense variants-that we demonstrate are pathogenic and causal of the disease presentation based on population frequency, homology modeling and functional studies that show the effects of the pathogenic variants on TARS2 stability and/or function.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Treonina-tRNA Ligase / Encefalomiopatias Mitocondriais / Doenças Mitocondriais Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Hum Mol Genet Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Treonina-tRNA Ligase / Encefalomiopatias Mitocondriais / Doenças Mitocondriais Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Hum Mol Genet Ano de publicação: 2022 Tipo de documento: Article